In vivo imaging, which enables us to peer deeply within living subjects, is producing
tremendous opportunities both for clinical diagnostics and as a research tool. Contrast …

Positron emission tomography (PET) and magnetic resonance imaging (MRI) have both
been used for decades in cardiovascular imaging. Since 2010, hybrid PET/MRI using …

The use of cardiac PET, and in particular of quantitative myocardial perfusion PET, has been
growing during the last years, because scanners are becoming widely available and …

The Japanese Circulation Society (JCS) published the “Guidelines for elective percutaneous
coronary intervention [PCI] in patients with stable coronary disease” in 2000. In 2006 …

Tissue macrophage numbers vary during health versus disease. Abundant inflammatory
macrophages destruct tissues, leading to atherosclerosis, myocardial infarction and heart …

Myocardial infarction (MI) is the leading cause of morbidity and mortality worldwide. Despite
extensive efforts to provide early diagnosis and adequate treatment regimens, detection of …

Cardiovascular imaging has largely focused on identifying structural, functional, and
metabolic changes in the heart. The ability to reliably assess disease activity would have …

Purpose Develop a framework for efficient free‐breathing simultaneous whole‐heart
coronary magnetic resonance angiography (CMRA) and cardiac positron emission …

When this article was written, it coincided with the 11th anniversary of the installation of our
PET/MR device in Munich. In fact, this was the first fully integrated device to be in clinical …

Background—Hybrid positron emission tomography and magnetic resonance allows the
advantages of magnetic resonance in tissue characterizing the myocardium to be combined …